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Low-neurovirulence BeAn and DA Theiler’s murine encephalomyelitis viruses (TMEV) cause persistent infection in the
central nervous system (CNS) of susceptible mouse strains, leading to an inflammatory demyelinating process. A role for a
specific virus–cell receptor interaction has been posited to explain why only low- and not high-neurovirulence TMEV cause
persistent CNS infections. Low- but not high-neurovirulence TMEV use sialic acid for attachment to mammalian cells, which
may contribute to neurovirulence attenuation and viral persistence. Analysis of BeAn virus binding and infection in cells with
altered (mutated) cell-surface expression of sialic acid containing glyconjugates indicated that both binding and infection are
mediated entirely by N-linked glycoproteins. By contrast, GDVII virus binding and infection appears to be dependent only in
part on N-linked glycoproteins and not on O-linked glycoproteins or glycolipids. These results indicate that low-neuroviru-
lence BeAn virus uses a sialic acid moiety expressed on an N-linked carbohydrate of a glycoprotein that serves as the proteinlic acidKey Words: Theiler’s murine encephalomyelitis virus; sia
INTRODUCTION
Theiler’s murine encephalomyelitis virus (TMEV), an
enteric pathogen of mice, belongs to the Cardiovirus
genus in the Picornaviridae family (Pevear et al., 1987).
TMEV consists of two groups based on neurovirulence in
intracerebrally (ic) inoculated mice; high-neurovirulence
strains, such as GDVII, produce acute encephalitis in
mice, whereas low-neurovirulence TMEV, such as BeAn
and DA, produces persistent central nervous system
(CNS) infection of susceptible mouse strains, leading to
an inflammatory demyelinating process (Lipton, 1975;
Lehrich et al., 1976). Infection of mice with the low-
neurovirulence TMEV has been studied extensively be-
cause of similarities between the experimental demyeli-
nating disease and multiple sclerosis.
A role for TMEV–cell receptor interaction(s) has been
postulated to explain why only the low-neurovirulence
TMEV cause persistent infections (Adami et al., 1997;
Jarousse et al., 1994). Low-neurovirulence TMEV appear
to use sialic acid for attachment (Fotiadis et al., 1991;
Zhou et al., 1997, 2000) and a protein entry receptor for
internalization into the cell. Virus overlay protein blot
assay of ligand binding indicates the use of a 34-kDa
protein entry receptor (Kilpatrick and Lipton, 1991). Re-
cently, Hertzler et al. (2001) demonstrated that the uridine
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diphosphate (UDP) galactose transporter found in the
trans-Golgi apparatus is required for binding and infec-
tion of both high- and low-neurovirulence TMEV. Galac-
tose is the penultimate sugar required for addition of
terminal sialic acid to glycoproteins and glycolipids (Ta-
ble 1) and is also a component of the tetrasaccharide
linker in proteoglycan synthesis. Thus, loss of galactose
could affect virus binding to glycoproteins, glycolipids,
and proteoglycans.
To further dissect the role of carbohydrates in TMEV
binding and infection, we analyzed BeAn infection of
cells with defective surface expression of sialic acid
containing glycoconjugates, e.g., N-, O-, and lipid-linked
oligosaccharides, and compared the results with those
for GDVII virus binding and infection. We find that BeAn
virus binding and infection is mediated entirely by N-
linked glycoproteins, whereas GDVII virus binding and
infection is only partially dependent on N-linked glycop-
roteins. Indeed, GDVII virus binding and infection was
recently shown to depend on heparan sulfate proteogly-
cans (Reddi and Lipton, 2002).
RESULTS
BeAn virus uses sialic acid moieties for cell
attachment
Treatment of BHK-21 cells with Clostridium perfringens
neuraminidase resulted in greater than 90% reduction ofentry receptor. © 2002 Elsevier Science (USA)
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binding (Fig. 1), whereas binding of GDVII virus was
unaffected (not shown). A typical dose-response to in-
creasing neuraminidase concentrations was observed,
with maximal inhibition at 1 mU/ml (not shown). Treat-
ment of BHK-21 cells with Vibrio cholera neuraminidase
also abrogated BeAn virus binding (not shown). Neur-
aminidase treatment of BHK-21 cells showed a similar
effect on infection (Fig. 2). To determine whether BeAn
virus requires cell-surface sialic acid for binding to other
mammalian cells, BeAn virus binding to neuraminidase-
treated Jurkat cells, a human T lymphocyte line, was
examined and reduced by 92% (not shown), and that to
Lec-2 and Lec-8 cells, mutant Chinese hamster ovary
(CHO) cells lacking the CMP sialic acid and UDP galac-
tose transporters, respectively, was reduced by more
than 90% compared to parental CHO cells (Fig. 3). Re-
sults of infection of these cells paralleled viral binding
(Fig. 2). Thus, consistent with previous results (Fotiadis
et al., 1991), cell-surface sialic acid is necessary for
attachment and infection of BeAn but not GDVII virus to
mammalian cells.
BeAn virus does not use sialic acid on glycolipids or
O-linked oligosaccharides for cell attachment
Since loss of the UDP galactose transporter activity in
the trans-Golgi network eliminates TMEV binding (Hert-
zler et al., 2001; also see Lec-8 cells in Fig. 3), and the
penultimate galactose and terminal sugar sialic acid are
found on cell-membrane glycolipids, we examined the
role of gangliosides in TMEV attachment. Analysis of
BeAn binding in glycolipid-deficient GM95 cells and pa-
rental glycolipid-expressing MEB4 cells revealed no sig-
nificant difference, whereas GDVII virus-binding levels
were 2.5-fold higher in the glycolipid-deficient GM95
cells than in parental MEB4 (Fig. 4A). Despite the differ-
ence in GDVII virus binding, infection as measured by
MTT assay was similar in both cell lines (Fig. 2). In
BHK-21 cells treated with the ceramide synthase inhibi-
tor, fumonisin B1, to abrogate ganglioside expression,
binding of the lectin Mal I (Wang et al., 1991) was pro-
portionately decreased as expected (P  0.01). Although
fumonisin B1 treated BHK-21 cells showed morphologi-
cal changes (not shown), binding of both TMEV was
unaffected (Fig. 4B). Thus, BeAn virus does not attach to
sialic acid on glycolipids, while GDVII virus binding is
enhanced in the absence of glycolipids. Lack of en-
hanced GDVII virus binding by fumonisin B1 may be due
to less efficient or a difference in glycolipid removal.
The effect of altered cellular O-linked carbohydrate
expression on virus attachment and infection was exam-
TABLE 1
Complex Oligosaccharide Structures Dependent
on Galactose Linkages
Galactose and
sialic acid moiety Inhibitor References
N-linked Tunicamycin McDowell et al., 1988
1-Deoxymannojirimycin Saunier et al., 1982
O-linked BenzylGalNAc Huet et al., 1996
Lipid-linked Fumonisin B1 Wang et al., 1991
FIG. 1. BeAn virus binding to BHK-21 cells as measured by radiolabeled virus association (A) or flow cytometry (B and C). (A) Purified 35S-labeled
BeAn virus (1  106 cpm) was incubated with 1  106 BHK-21 cells at 4°C for varying times and washed extensively. BHK-21 cells were either treated
with 1 mU/ml of Clostridium perfringens neuraminidase for 45 min at 37°C (F) or mock treated (f). Cell-associated radioactivity was measured with
a scintillation counter and plotted as described (Hertzler et al., 2000); V0 is the total amount of virus particles added to 1  10
6 cells and V t is the
unattached virus in a period of time. (B) Neuraminidase- or mock-treated BHK-21 cells (1  106) were incubated with BeAn virus at an m.o.i. of 10
at 4°C for 45 min, washed, and successively incubated with mAb to TMEV VP1 and goat anti-mouse IgG-FITC. Plot of cell-associated fluorescence
measured with a flow cytometer. (C) BeAn and GDVII virus binding to neuraminidase-treated BHK-21 cells shown as mean fluorescence intensity 
SD compared to untreated cells.
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ined in ldlD cells, a CHO mutant with defective synthesis
of N-linked, O-linked, and lipid-linked glycoconjugates
due to loss of UDP-galactose/UDP-galactosamine-4-
epimerase activity; this defect is reversible by the addi-
tion of galactose and/or N-acetylgalactosamine to the
culture medium (Kingsley et al., 1986). O-linked glyco-
proteins require addition of both sugars for proper ex-
pression while the other glycoconjugates require only
the addition of galactose. Neither TMEV nor the Mal I
lectin bound to ldlD cells grown in the absence of the two
sugars, but addition of 20 M galactose to the culture
medium restored binding and infection of both viruses
and Mal I (Figs. 2 and 5A). Addition of both 20 M
galactose and 200 M N-acetylgalactosamine to the
culture medium did not alter TMEV binding of ldlD cells
as compared with addition of galactose alone (not
shown). TMEV binding and infection was also examined
in HT-29 human colorectal adenocarcinoma cells treated
with benzyl 2-acetamido-2-deoxy--D-galactopyranoside
(BenzylGalNAc), a metabolic inhibitor that reduces cell-
surface sialic acid associated with O-linked carbohy-
drates (Huet et al., 1996). BenzylGalNAc has been dem-
onstrated to be an effective inhibitor of O-linked glyco-
sylation in HT-29 cells (Huet et al., 1998). After treatment,
these cells were morphologically heterogeneous (not
shown), and binding of the O-linked carbohydrate-spe-
cific lectin jacalin was decreased by 33% (P  0.005),
but binding of both TMEV remained unchanged (Fig. 5B).
Similar results were obtained using BenzylGalNAc-
FIG. 2. BeAn and GDVII virus infection was carried out for 20 h in
cells treated with listed reagents or in mutant cell lines. Cell viability
was measured by MTT assay. All experiments were performed in
triplicate and results presented as percentage of cell survival com-
pared to mock-infected cells  SD. BeAn virus infection was substan-
tially reduced only under conditions in which cell-surface sialic acid or
N-linked oligosaccharides were removed. GDVII virus infection was
reduced only in conditions in which galactose processing was aberrant
and was unaffected by N-linked oligosaccharide processing defects.
FIG. 3. BeAn and GDVII virus binding to Lec cell mutants. Viral
binding was measured by flow cytometry and compared to binding of
parental CHO cells. Lec-2 and Lec-8 cells have defects in the CMP
sialic acid and UDP galactose transporters, respectively, while Lec-1
cells are defective in N-linked carbohydrate processing. Data are given
as % mean fluorescent intensity  SD.
FIG. 4. (A) BeAn and GDVII virus binding to ganglioside-deficient
GM-95 cells compared to parental, ganglioside-containing MEB-4
mouse melanoma cells. (B) BeAn virus, GDVII virus, and Mal I binding
to fumonisin B1-treated BHK-21 cells. Cells were grown in media
containing 10 mM fumonisin B1 for 48 h before viral binding. Viral and
lectin binding was measured by flow cytometry, and the mean fluores-
cent intensity  SD was determined by comparison with untreated
cells.
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treated BHK-21 cells (not shown). Together, these results
indicate that neither BeAn nor GDVII virus requires O-
linked carbohydrates for cell-surface attachment or for
infection.
BeAn virus uses sialic acid on N-linked
oligosaccharides for cell attachment
To examine the role of N-linked glycosylation in TMEV
binding and infection, BHK-21 cells were treated with
tunicamycin, a fungal toxin that blocks assembly of N-
acetylglucosamine on the lipid carrier dolichol phos-
phate, or with 1-deoxymannojirimycin, which blocks pro-
cessing by -mannosidase I (McDowell and Schwarz,
1988; Saunier et al., 1982); both toxins inhibit early steps
in the assembly of N-linked carbohydrates. BeAn virus
binding to cells treated with either toxin was decreased
by more than 75%, whereas GDVII virus binding was
reduced by only 20% (Fig. 6). On the other hand, no
inhibition of GDVII virus infection was observed in cells
treated with these metabolic inhibitors (Fig. 2). These
results indicate that the sialic acid moieties important for
BeAn virus attachment and infection are found on N-
linked glycoproteins, whereas N-linked glycoproteins
probably account for only a minor portion of GDVII virus
binding. Further analysis of the role of N-linked oligosac-
charides in BeAn virus binding using cell-membrane
extracts digested with varying concentrations of PNGase
F, an N-linked specific endoglycosidase, or neuramini-
dase, blotted onto nitrocellulose filters and overlaid with
35S-labeled BeAn virus, revealed abrogation of BeAn vi-
FIG. 6. BeAn and GDVII virus binding to cells treated with tunicamy-
cin or 1-deoxymannojirimycin. (A) Viral binding to BHK-21, Neuro2A, or
M1D cells treated with tunicamycin. Cells were grown in medium
containing 20 g/ml tunicamycin for 48 h before viral binding. Virus
binding was measured by flow cytometry and the mean fluorescent
intensity  SD determined by comparison with untreated cells. BeAn
virus binding was substantially reduced, while that of GDVII was only
moderately affected after treatment. (B) Virus binding to BHK-21 cells
was carried out as in (A) except that 20 g/ml of 1-deoxy-
mannojirimycin was used. BeAn but not GDVII virus binding was
substantially reduced.
FIG. 5. (A) Virus binding to glycoconjugate-deficient ldlD cells grown
in medium in the absence or presence of 20 mM galactose. Without
added galactose, ldlD cells do not express N- or O-linked carbohy-
drates while cells grown in media containing galactose express car-
bohydrates chains only on N-linked glycoproteins and glycolipids.
Restoration of viral binding by addition of galactose only demonstrates
that O-linked carbohydrates are not necessary for cell-surface attach-
ment of TMEV. (B) BeAn, GDVII, and jacalin binding to BenzylGalNac-
treated HT-29 cells. Cells were grown in medium containing 20 mM
BenzylGalNac for 96 h before viral binding. Virus and lectin binding was
measured by flow cytometry and compared to untreated cells. Cell-
surface O-linked carbohydrates were reduced, as evidenced by reduc-
tion in jacalin binding, but BeAn or GDVII virus binding remained
unchanged. Viral and lectin binding was measured by flow cytometry
and the mean fluorescent intensity  SD determined by comparison
with untreated cells.
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rus binding to membrane extracts digested with either
enzyme (Fig. 7). Digestion with O-glycanase could not be
carried out because prior treatment with neuraminidase
is required for enzymatic activity (Umemoto et al., 1977).
BeAn virus uses sialic acid on N-linked
oligosaccharides on cell lines representing the
principal cellular targets in the mouse CNS
BeAn virus principally replicates in neurons during the
acute phase of infection and macrophages/microglia
during viral persistence in the mouse CNS (Lipton et al.,
1995; Aubert and Brahic, 1995). Therefore, we examined
whether BeAn virus utilizes N-linked oligosaccharides
for binding and infection of a murine neuronal cell line
(Neuro2A neuroblastoma cells) and differentiated murine
macrophages (M1D cells). Tunicamycin treatment of
both cell lines resulted in a marked decrease in BeAn
virus binding and infection; however, there was little
effect on GDVII binding and infection (Figs. 2 and 6A).
This result suggests that low-neurovirulence TMEV also
use sialic acid on N-linked oligosaccharides in infections
of the mouse CNS.
DISCUSSION
Members of both TMEV neurovirulence groups require
galactose for attachment to cells (Hertzler et al., 2001),
but our present results indicate that the galactose resi-
dues are present on different molecules. Our study lo-
calizes the sialic acid moiety necessary for BeAn virus
attachment and infection to a complex type N-linked
oligosaccharide structure. The sialic acid residues found
on O-linked carbohydrates and glycolipids are not
needed for BeAn attachment. Most likely, BeAn virus
binds a sialic acid residue with an 2–3 linkage, since (1)
sialic acids on N-linked carbohydrates are principally
linked to the penultimate galactose residue by this link-
age (Dell and Morris, 2001); (2) BeAn binding is blocked
by 2–3-linked siallylactose (Zhou et al., 1997); and (3)
the lectin Maackia amurensis (Mal 1), which recognizes
the galacosyl 1,4-N-acetylglucosamine linkage alone or
with 2,3- but not 2,6-linked sialic acid partially blocks
BeAn infection (submitted for publication). In contrast to
BeAn virus, GDVII requires galactose residues located in
the tetrasaccharide linker of heparan sulfate proteogly-
can for attachment (Reddi and Lipton, 2002).
The finding that expression of the UDP galactose
transporter (UGT) in a TMEV receptor-negative mutant
cell line restored viral binding and infection (Hertzler et
al., 2001) pointed to UGT itself as a TMEV receptor
protein candidate. Although UGT resides in the trans-
Golgi network, the transporter may reach the cell surface
since other trans-Golgi proteins are known to cycle to the
plasma membrane in exocytic transport vesicles along
with their glycoprotein products and return to the trans-
Golgi network via the endocytic pathway (Ladinsky and
Howell, 1993; Shukla et al., 1999). However, rabbit poly-
clonal antibodies to human UGT do not block TMEV
binding or infection of BHK-21 cells (submitted for pub-
lication), suggesting that UGT is not a TMEV receptor
protein.
The ability to express receptor proteins in cells has
enabled a distinction between attachment and infection,
functions that may be mediated by the same or different
receptors (Evans and Almond, 1998). We believe that two
receptors are necessary for BeAn virus attachment and
infection. The involvement of sialic acid residues on a
specific subset of cell-surface structures suggests that
the sialic acid binding properties of BeAn virus are not
promiscuous and couple binding of this carbohydrate to
a specific protein receptor. Virus overlay assays have
provided evidence for the binding of a protein receptor
(Kilpatrick and Lipton, 1991; Libbey et al., 2001). Further-
more, BeAn competitively inhibits the binding of GDVII
virus, but GDVII does not competitively inhibit BeAn virus
(Fotiadis et al., 1991). The nonreciprocal TMEV blocking
results are similar to those reported for reovirus serotype
3 strains, which differ in their capacity to bind sialic acid
(Barton et al., 2001). The two TMEV strains may bind
different regions of the same protein with BeAn attaching
to a more distal site, consistent with the notion of BeAn
attachment to both a terminal sialic acid residue and a
protein sequence or conformation. Our preliminary ob-
servations suggest that BeAn binds to a sialic acid res-
idue linked to a specific protein (model 1); however, the
data presented here do not distinguish between this
possibility and the virus binding to sialic acid on a gly-
coprotein and then to another protein entry receptor that
is not glycosylated (model 2).
The utilization of carbohydrates for cellular attachment
is uncommon among picornaviruses. Virulent or field
strains of foot-and-mouth disease virus and echovirus-6
have been shown to rely on heparan sulfate as an at-
tachment factor in vitro (Jackson et al., 1996; Goodfellow
et al., 2001), and rhinovirus 87 binds sialic acid (Un-
capher et al., 1991). These viruses also bind to known
protein receptors to gain entry into the cell. However, the
simultaneous binding of sialic acid and peptide compo-
FIG. 7. Binding of 35S-labeled BeAn virus binding to enzyme-treated
BHK-21 cell-membrane preparations. BHK-21 membrane proteins were
treated with PNGase F or Clostridium perfringens neuraminidase and
blotted onto nitrocellulose filters and incubated with 1  106 cpm of
35S-labeled BeAn virus. Cleavage of N-linked carbohydrates and sialic
acid substantially reduced viral binding.
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nents of the same glycoprotein would be a feature
unique to low-neurovirulence TMEV.
Zhou et al. (2000) have solved the crystal structure at
3.0 A of the low-neurovirulence DA strain bound to 2,3-
siallylactose, revealing the binding site for sialic acid in
a positively charged area on VP2 puff B. Four contacts
are formed through hydrogen bonds between molecules
of N-acetyl neuraminic acid and VP2 amino acids 161,
163, and 174, and VP3 residue 232. The three VP2 resi-
dues on puff B are located 20–30 A from a depression on
the cardiovirion protomer, termed the pit, which is be-
lieved to be the docking site for the cellular receptor
protein. In fact, mutation of four residues in the BeAn
virus pit has indicated that these residues are involved in
BeAn virus infection (Hertzler et al., 2000). Clearly, the pit
residues are not responsible for attachment to sialic
acid, further supporting the use of both sialic acid and a
protein for attachment and internalization of low-neuro-
virulence TMEV. We are currently mutating the three VP2
puff residues that make contact with sialic acid to test for
a role in attachment; VP3 residue 232 located in the
cleavage dipeptide between VP3 and VP1 cannot be
changed.
Our results provide evidence for a differential receptor
interaction between high- and low-neurovirulence TMEV.
Both viruses may attach to the same protein receptor;
however, the disruptions of carbohydrate additions de-
scribed here only inhibit BeAn attachment. The utilization
of different surface structures for cellular attachment
may underlie the differences in tissue tropism and neu-
rovirulence for each virus. In this context, it will be inter-
esting to compare posttranslational modifications of neu-
ronal vs glial and macrophage cell membranes, the cells
in which low-neurovirulence TMEV persist. Identification
of the protein receptor and an understanding of its ex-
pression and modification may also help explain the




BeAn and GDVII virus stocks were prepared as clari-
fied lysates in BHK-21 cells, with titers  108 PFU/ml, as
described (Rozhon et al., 1983). BeAn virus was radiola-
beled and purified as described (Hertzler et al., 2000).
Cells
Baby hamster kidney (BHK-21) cells, the Pro-5 variant
of CHO cells, CHO glycosylation-deficient mutants Lec-1,
Lec-2, and Lec-8 cells, HT-29, human colorectal carci-
noma cells, glycoconjugate-deficient ldlD cells, and
Neuro2A cells were obtained from American Type Cul-
ture Collection. MEB-4 mouse B16 melanoma and GM-95
ganglioside mutant cells (Ichikawa et al., 1994; Saunier
et al., 1982) were obtained from the RIKEN Cell Bank
(Tokyo, Japan). M1D macrophages were derived from the
myeloid precursor M1 cells and maintained as described
(Jelachich et al., 1999). BHK-21 cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM) supple-
mented with 2 mM L-glutamine, 100 mg/ml streptomycin,
100 U/ml penicillin, 7.5% fetal bovine serum (FBS), and 6.5
mg/ml tryptose phosphate broth (Gibco-BRL) at 37°C in a
5% CO2 atmosphere. CHO, Lec-1, Lec-2, and Lec-8 cells
were grown in minimum essential medium (-MEM) sup-
plemented with 2 mM L-glutamine, 100 mg/ml streptomy-
cin, 100 U/ml penicillin, and 10% FBS. HT-29 cells were
grown in McCoy’s 5a medium with 1.5 mM L-glutamine,
100 mg/ml streptomycin, 100 U/ml penicillin, and 10%
FBS. ldlD cells were grown in Ham’s F12 medium sup-
plemented with 2 mM L-glutamine, 1% ITS1 (insulin,
transferrin, selenium, linoleic acid, and bovine serum
albumin (BSA) supplement; Sigma), 100 mg/ml strepto-
mycin, 100 U/ml penicillin, and 5% FBS. MEB-4 and
GM-95 cells were grown in DMEM supplemented with
100 mg/ml streptomycin, 100 U/ml penicillin, and 10%
FBS. Neuro2A cells were grown in MEM supplemented
with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 0.1
mM nonessential amino acids, 1 mM sodium pyruvate,
and 10% FBS.
Reagents
V. cholera and C. perfringens neuraminidase, tunica-
mycin, 1-deoxymannojirimycin, BenzylGalNAc, fumonisin
B1, and PNGase F were purchased from Sigma. The
lectins Mal I and jacalin were purchased from Vector
Laboratories. mAb 6F7 to TMEV VP1 was kindly provided
by Raymond Roos at the University of Chicago.
Binding assays
Binding of virus to cells in suspension was determined
by flow cytometry and with radiolabeled virus as de-
scribed (Jelachich and Lipton, 2001; Hertzler et al., 2001).
Briefly, 106 cells were washed with phosphate-buffered
saline (PBS), pH 7.2, containing calcium and magnesium,
and incubated with virus for 45 min at 4°C. Cells were
washed with PBS containing 0.5% FBS (PBS-FACS),
blocked with 10 l of normal goat serum for 15 min at
4°C, and incubated with 1 g of mAb 6F7 to TMEV VP1
for 30 min at 4°C followed by 1 g of goat anti-mouse
IgG-FITC conjugate for 30 min at 4°C. After three washes
with PBS-FACS, cells were fixed with 1% paraformalde-
hyde and analyzed on a FACSCalibur (Becton-Dickinson,
Palo Alto, CA). Lectin binding to cells was determined
using 1 g of biotin-conjugated Mal I or jacalin followed
by avidin-FITC. Mean fluorescence intensity (SD) of
triplicate samples was determined and the experiment
repeated at least three times. Results from three sam-
ples were analyzed using the Student’s t test.
Binding was also assayed by attachment of 35S-la-
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beled BeAn virus to BHK-21 cells. BHK-21 cells were
detached from monolayers with PBS without calcium and
magnesium, washed, and resuspended to a concentra-
tion of 106 cells/ml in DMEM containing 20 mM HEPES
and 1% BSA and incubated on ice for 1 h before addition
of [35S]methionine-labeled virus (20,000 particles/cell). At
indicated times, an aliquot of the virus-cell suspension
was removed and diluted in DMEM containing 20 mM
HEPES before centrifugation at 12,000 g for 30 s. Super-
natant- and cell-associated radioactivity was determined
for triplicate samples in a Beckman LS5000TD scintilla-
tion counter and plotted as a percentage of cell-associ-
ated counts.
Infectivity assay of cell survival
Cells were grown to 80% confluency in 24-well plates,
treated- or mock-treated with reagents as described,
followed by infection with BeAn or GDVII virus at an m.o.i.
of 10 (absorption for 45 min at 24°C), and incubated in
maintenance medium for 20 h. Cell viability was mea-
sured by MTT assay as described (Denziot and Lang,
1986).
Extraction of cell membranes
BHK-21 cells (1  108) were washed with PBS, resus-
pended in 10 ml of PBS with the mammalian protease
inhibitor cocktail (Sigma), homogenized with 20 strokes
of a Dounce homogenizer, and examined for lysis by
trypan blue exclusion. The lysate was centrifuged at
2000 g for 10 min; the recovered supernatant was cen-
trifuged at 40,000 g for 30 min, and the pellet was resus-
pended in 200 l of PBS containing 0.1% -octylglu-
coside and protease inhibitor cocktail and assayed for
protein concentration using the Pierce BCA protocol.
Membrane preparations were mock-, neuraminidase-, or
PNGaseF-treated at various concentrations.
Dot blots
One or five micrograms of BHK-21 membrane protein
preparation was blotted onto nitrocellulose membranes
blocked with 5% BSA as described (Kilpatrick and Lipton,
1991). 35S-labeled-BeAn virus (1  106 cpm) in a volume
sufficient to cover the membrane was added and incu-
bated for 2 h at 24°C and autoradiographed for 12–24 h.
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